New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Breast density varies in racial/ethnic groups after BMI adjustment

Breast density varies in racial/ethnic groups after BMI adjustment

by Elana GotkineAfter adjustment for body mass index (BMI), clinically important differences in the prevalence of dense breasts persist across racial/ethnic groups, according to a study published onli
World medicine December 07,2023
Breast density varies in racial/ethnic groups after BMI adjustment

Breast density varies in racial/ethnic groups after BMI adjustment

by Elana GotkineAfter adjustment for body mass index (BMI), clinically important differences in the prevalence of dense breasts persist across racial/ethnic groups, according to a study published onli
World medicine December 07,2023
Investigating the association between inflammation and treatment related symptoms in gynecologic cancers

Investigating the association between inflammation and treatment related symptoms in gynecologic cancers

byH. Lee Moffitt Cancer Center & Research InstituteLeast square mean levels over time for patients with gynecologic cancer and non-cancer controls for (A) IL-10, (B) IL-1B, (C) TNF-alpha, (D
World medicine December 07,2023
Investigating the association between inflammation and treatment related symptoms in gynecologic cancers

Investigating the association between inflammation and treatment related symptoms in gynecologic cancers

byH. Lee Moffitt Cancer Center & Research InstituteLeast square mean levels over time for patients with gynecologic cancer and non-cancer controls for (A) IL-10, (B) IL-1B, (C) TNF-alpha, (D
World medicine December 07,2023
Most pancreatic cancer patients do not get lifesaving surgery, says Texas study

Most pancreatic cancer patients do not get lifesaving surgery, says Texas study

byUT Southwestern Medical CenterTrend over time of the rate of curative-intent surgical resection and reason for lack of surgery in patients with early-stage pancreatic cancer (2004–2018). Credi
World medicine December 07,2023
Most pancreatic cancer patients do not get lifesaving surgery, says Texas study

Most pancreatic cancer patients do not get lifesaving surgery, says Texas study

byUT Southwestern Medical CenterTrend over time of the rate of curative-intent surgical resection and reason for lack of surgery in patients with early-stage pancreatic cancer (2004–2018). Credi
World medicine December 07,2023
Gene p16, which drives colorectal cancer, is emerging as a target for potential therapies

Gene p16, which drives colorectal cancer, is emerging as a target for potential therapies

by Homa Shalchi,Baylor College of MedicineEngineeredp16epimutation recapitulates key features of age-associated epigenetic silencing.Ap16DNA methylation profiles in
World medicine December 07,2023
Gene p16, which drives colorectal cancer, is emerging as a target for potential therapies

Gene p16, which drives colorectal cancer, is emerging as a target for potential therapies

by Homa Shalchi,Baylor College of MedicineEngineeredp16epimutation recapitulates key features of age-associated epigenetic silencing.Ap16DNA methylation profiles in
World medicine December 07,2023
Multiclonality of estrogen receptor expression in ductal carcinoma in situ (DCIS)

Multiclonality of estrogen receptor expression in ductal carcinoma in situ (DCIS)

by Impact Journals LLCMulti-clonal ER expression in DCIS. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28450A new editorial paper titled "Multiclonality of ER expression in DCIS—
World medicine December 07,2023
Multiclonality of estrogen receptor expression in ductal carcinoma in situ (DCIS)

Multiclonality of estrogen receptor expression in ductal carcinoma in situ (DCIS)

by Impact Journals LLCMulti-clonal ER expression in DCIS. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28450A new editorial paper titled "Multiclonality of ER expression in DCIS—
World medicine December 07,2023
Discovery of protein-protein interaction lays foundation for future glioblastoma therapy

Discovery of protein-protein interaction lays foundation for future glioblastoma therapy

byThe Hospital for Sick ChildrenA fluorescent image of glioblastoma cells (green) scattered among health brain tissue (blue). Credit: The Hospital for Sick Children (SickKids).The discovery of a
World medicine December 07,2023
Discovery of protein-protein interaction lays foundation for future glioblastoma therapy

Discovery of protein-protein interaction lays foundation for future glioblastoma therapy

byThe Hospital for Sick ChildrenA fluorescent image of glioblastoma cells (green) scattered among health brain tissue (blue). Credit: The Hospital for Sick Children (SickKids).The discovery of a
World medicine December 07,2023
Single-cell study uncovers distinct immunosuppressive tumor microenvironment in brain metastases from kidney cancer

Single-cell study uncovers distinct immunosuppressive tumor microenvironment in brain metastases from kidney cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainIn a new study, researchers from The University of Texas MD Anderson Cancer Center have created the largest sin
World medicine December 07,2023
Single-cell study uncovers distinct immunosuppressive tumor microenvironment in brain metastases from kidney cancer

Single-cell study uncovers distinct immunosuppressive tumor microenvironment in brain metastases from kidney cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainIn a new study, researchers from The University of Texas MD Anderson Cancer Center have created the largest sin
World medicine December 07,2023
Single-dose HPV vaccine effective in preventing cervical cancer globally

Single-dose HPV vaccine effective in preventing cervical cancer globally

byLondon School of Hygiene & Tropical MedicineOverview of the data sources and the key steps of the modeling. Credit:BMC Medicine(2023). DOI: 10.1186/s12916-023-02988-3Administer
World medicine December 07,2023
Single-dose HPV vaccine effective in preventing cervical cancer globally

Single-dose HPV vaccine effective in preventing cervical cancer globally

byLondon School of Hygiene & Tropical MedicineOverview of the data sources and the key steps of the modeling. Credit:BMC Medicine(2023). DOI: 10.1186/s12916-023-02988-3Administer
World medicine December 07,2023
Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

by Thamarasee Jeewandara , Medical XpressIn situ vaccination with single-dose NvIH reduced TME immunosuppression, enhanced TME antitumor immune milieu, and elicited systemic antitumor immunity, result
World medicine December 07,2023
Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

by Thamarasee Jeewandara , Medical XpressIn situ vaccination with single-dose NvIH reduced TME immunosuppression, enhanced TME antitumor immune milieu, and elicited systemic antitumor immunity, result
World medicine December 07,2023
Drug with a light switch: Researcher investigates chemotherapy without side effects

Drug with a light switch: Researcher investigates chemotherapy without side effects

byLeiden UniversityCredit: Leiden UniversityNausea, neurologic pain and hair loss are some of the severe side effects of chemotherapy. But they are not a necessary hardship, says biochemist Liya
World medicine December 07,2023
Drug with a light switch: Researcher investigates chemotherapy without side effects

Drug with a light switch: Researcher investigates chemotherapy without side effects

byLeiden UniversityCredit: Leiden UniversityNausea, neurologic pain and hair loss are some of the severe side effects of chemotherapy. But they are not a necessary hardship, says biochemist Liya
World medicine December 07,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com